{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:06:43Z","timestamp":1793394403253,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CURR MED SCI"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s11596-025-00052-0","type":"journal-article","created":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T07:40:19Z","timestamp":1745998819000},"page":"430-437","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Biomarker-Based Models Utilizing the Albumin-Fibrinogen Ratio Effectively Predict Peritoneal Metastasis in Patients with Gastric Cancer: A Retrospective Study"],"prefix":"10.1007","volume":"45","author":[{"given":"Chun-yang","family":"Shang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-pu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-song","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang-shuai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-quan","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,30]]},"reference":[{"issue":"8","key":"52_CR1","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1097\/JS9.0000000000000457","volume":"109","author":"M Patel","year":"2023","unstructured":"Patel M, Arora A, Mukherjee D, et al. Effect of hyperthermic intraperitoneal chemotherapy on survival and recurrence rates in advanced gastric cancer: a systematic review and meta-analysis. Int J Surg. 2023;109(8):2435\u20132450.","journal-title":"Int J Surg."},{"issue":"25","key":"52_CR2","doi-asserted-by":"publisher","first-page":"41549","DOI":"10.18632\/oncotarget.14607","volume":"8","author":"W Ge","year":"2017","unstructured":"Ge W, Chen G, Fan XS. Pathway of peritoneal carcinomatosis maybe hematogenous metastasis rather than peritoneal seeding. Oncotarget. 2017;8(25):41549\u201341554.","journal-title":"Oncotarget."},{"issue":"Suppl 1","key":"52_CR3","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s10120-016-0660-y","volume":"20","author":"K Kono","year":"2017","unstructured":"Kono K, Yong WP, Okayama H, et al. Intraperitoneal chemotherapy for gastric cancer with peritoneal disease: experience from Singapore and Japan. Gastric Cancer. 2017;20(Suppl 1):122\u2013127.","journal-title":"Gastric Cancer."},{"issue":"1","key":"52_CR4","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/s41467-020-20429-0","volume":"12","author":"D Chen","year":"2021","unstructured":"Chen D, Liu Z, Liu W, et al. Predicting postoperative peritoneal metastasis in gastric cancer with serosal invasion using a collagen nomogram. Nat Commun. 2021;12(1):179.","journal-title":"Nat Commun."},{"issue":"4","key":"52_CR5","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1308\/rcsann.2018.0011","volume":"100","author":"M Hasbahceci","year":"2018","unstructured":"Hasbahceci M, Malya FU, Kunduz E, et al. Use of serum and peritoneal CEA and CA19-9 in prediction of peritoneal dissemination and survival of gastric adenocarcinoma patients: are they prognostic factors? Ann R Coll Surg Engl. 2018;100(4):257\u2013266.","journal-title":"Ann R Coll Surg Engl."},{"issue":"7225","key":"52_CR6","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/457036b","volume":"457","author":"A Mantovani","year":"2009","unstructured":"Mantovani A. Cancer: Inflaming metastasis. Nature. 2009;457(7225):36\u201337.","journal-title":"Nature."},{"key":"52_CR7","doi-asserted-by":"publisher","first-page":"177","DOI":"10.2147\/CMAR.S343467","volume":"14","author":"Z Ye","year":"2022","unstructured":"Ye Z, Yu P, Cao Y, et al. Prediction of Peritoneal Cancer Index and Prognosis in Peritoneal Metastasis of Gastric Cancer Using NLR-PLR-DDI Score: A Retrospective Study. Cancer Manag Res. 2022;14:177\u2013187.","journal-title":"Cancer Manag Res."},{"issue":"1","key":"52_CR8","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12957-019-1651-3","volume":"17","author":"N Nakamura","year":"2019","unstructured":"Nakamura N, Kinami S, Fujii Y, et al. The neutrophil\/lymphocyte ratio as a predictor of peritoneal metastasis during staging laparoscopy for advanced gastric cancer: a retrospective cohort analysis. World J Surg Oncol. 2019;17(1):108.","journal-title":"World J Surg Oncol."},{"issue":"4","key":"52_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0175074","volume":"12","author":"XD Chen","year":"2017","unstructured":"Chen XD, Mao CC, Wu RS, et al. Use of the combination of the preoperative platelet-to-lymphocyte ratio and tumor characteristics to predict peritoneal metastasis in patients with gastric cancer. PLoS One. 2017;12(4):e0175074.","journal-title":"PLoS One."},{"issue":"5","key":"52_CR10","first-page":"1482","volume":"82","author":"JP Colle","year":"1999","unstructured":"Colle JP, Mishal Z, Lesty C, et al. Abnormal fibrin clot architecture in nephrotic patients is related to hypofibrinolysis: influence of plasma biochemical modifications: a possible mechanism for the high thrombotic tendency? Thromb Haemost. 1999;82(5):1482\u20131489.","journal-title":"Thromb Haemost."},{"issue":"6","key":"52_CR11","first-page":"3511","volume":"35","author":"M Ohi","year":"2015","unstructured":"Ohi M, Mori K, Toiyama Y, et al. Preoperative prediction of peritoneal metastasis in gastric cancer as an indicator for neoadjuvant treatment. Anticancer Res. 2015;35(6):3511\u20133518.","journal-title":"Anticancer Res."},{"key":"52_CR12","doi-asserted-by":"publisher","first-page":"1418978","DOI":"10.1155\/2020\/1418978","volume":"2020","author":"C Yang","year":"2020","unstructured":"Yang C, Yang Y, Huang X, et al. A Nomogram Based on Clinicopathologic Features and Preoperative Hematology Parameters to Predict Occult Peritoneal Metastasis of Gastric Cancer: A Single-Center Retrospective Study. Dis Markers. 2020;2020:1418978.","journal-title":"Dis Markers."},{"key":"52_CR13","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.3389\/fonc.2019.01159","volume":"9","author":"C Huang","year":"2019","unstructured":"Huang C, Liu Z, Xiao L, et al. Clinical Significance of Serum CA125, CA19-9, CA72-4, and Fibrinogen-to-Lymphocyte Ratio in Gastric Cancer with Peritoneal Dissemination. Front Oncol. 2019;9:1159.","journal-title":"Front Oncol."},{"key":"52_CR14","doi-asserted-by":"crossref","unstructured":"Ajani JA, D\u2019Amico TA, Bentrem DJ, et al. Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022;20(2):167\u2013192.","DOI":"10.6004\/jnccn.2022.0008"},{"issue":"3","key":"52_CR15","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s10120-016-0633-1","volume":"20","author":"Y Sato","year":"2017","unstructured":"Sato Y, Ohnuma H, Nobuoka T, et al. Conversion therapy for inoperable advanced gastric cancer patients by docetaxel, cisplatin, and S-1 (DCS) chemotherapy: a multi-institutional retrospective study. Gastric Cancer. 2017;20(3):517\u2013526.","journal-title":"Gastric Cancer."},{"issue":"26","key":"52_CR16","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1200\/JCO.20.02914","volume":"39","author":"YK Kang","year":"2021","unstructured":"Kang YK, Yook JH, Park YK, et al. PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer. J Clin Oncol. 2021;39(26):2903\u20132913.","journal-title":"J Clin Oncol."},{"issue":"8","key":"52_CR17","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41571-021-00492-2","volume":"18","author":"Y Nakamura","year":"2021","unstructured":"Nakamura Y, Kawazoe A, Lordick F, et al. Biomarker-targeted therapies for advanced-stage gastric and gastro-oesophageal junction cancers: an emerging paradigm. Nat Rev Clin Oncol. 2021;18(8):473\u2013487.","journal-title":"Nat Rev Clin Oncol."},{"issue":"6","key":"52_CR18","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1097\/RLU.0000000000002028","volume":"43","author":"P Perlaza","year":"2018","unstructured":"Perlaza P, Ortin J, Pages M, et al. Should 18F-FDG PET\/CT Be Routinely Performed in the Clinical Staging of Locally Advanced Gastric Adenocarcinoma? Clin Nucl Med. 2018;43(6):402\u2013410.","journal-title":"Clin Nucl Med."},{"issue":"5","key":"52_CR19","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1007\/s11605-020-04710-7","volume":"25","author":"N Hirahara","year":"2021","unstructured":"Hirahara N, Tajima Y, Matsubara T, et al. Systemic Immune-Inflammation Index Predicts Overall Survival in Patients with Gastric Cancer: A Propensity Score-Matched Analysis. J Gastrointest Surg. 2021;25(5):1124\u20131133.","journal-title":"J Gastrointest Surg."},{"issue":"6","key":"52_CR20","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.21037\/jgo-21-507","volume":"12","author":"X Wang","year":"2021","unstructured":"Wang X, He Q, Liang H, et al. A novel robust nomogram based on preoperative hemoglobin and albumin levels and lymphocyte and platelet counts (HALP) for predicting lymph node metastasis of gastric cancer. J Gastrointest Oncol. 2021;12(6):2706\u20132718.","journal-title":"J Gastrointest Oncol."},{"issue":"9","key":"52_CR21","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.29271\/jcpsp.2022.09.1154","volume":"32","author":"ZG Sargin","year":"2022","unstructured":"Sargin ZG, Dusunceli I. The Effect of HALP Score on the Prognosis of Gastric Adenocarcinoma. J Coll Physicians Surg Pak. 2022;32(9):1154\u20131159.","journal-title":"J Coll Physicians Surg Pak."},{"issue":"1","key":"52_CR22","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1177\/17246008211072875","volume":"37","author":"L Zhang","year":"2022","unstructured":"Zhang L, Qin S, Lu L, et al. Diagnostic value of combined prealbumin-to-fibrinogen and albumin-to-fibrinogen ratios in Hp-negative gastric cancer. Int J Biol Markers. 2022;37(1):66\u201373.","journal-title":"Int J Biol Markers."},{"issue":"9","key":"52_CR23","volume":"65","author":"C Liu","year":"2019","unstructured":"Liu C, Li X. Stage-Dependent Changes in Albumin, NLR, PLR, and AFR are Correlated with Shorter Survival in Patients with Gastric Cancer. Clin Lab. 2019;65(9):190132.","journal-title":"Clin Lab."},{"issue":"1","key":"52_CR24","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1186\/s12885-019-6143-x","volume":"19","author":"X You","year":"2019","unstructured":"You X, Zhou Q, Song J, et al. Preoperative albumin-to-fibrinogen ratio predicts severe postoperative complications in elderly gastric cancer subjects after radical laparoscopic gastrectomy. BMC Cancer. 2019;19(1):931.","journal-title":"BMC Cancer."},{"issue":"1","key":"52_CR25","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1245\/s10434-019-07624-0","volume":"27","author":"L Ji","year":"2020","unstructured":"Ji L, Selleck MJ, Morgan JW, et al. Gastric Cancer Peritoneal Carcinomatosis Risk Score. Ann Surg Oncol. 2020;27(1):240\u2013247.","journal-title":"Ann Surg Oncol."},{"issue":"2","key":"52_CR26","doi-asserted-by":"publisher","first-page":"197","DOI":"10.21147\/j.issn.1000-9604.2020.02.07","volume":"32","author":"X Chen","year":"2020","unstructured":"Chen X, Chen S, Wang X, et al. Analysis and external validation of a nomogram to predict peritoneal dissemination in gastric cancer. Chin J Cancer Res. 2020;32(2):197\u2013207.","journal-title":"Chin J Cancer Res."},{"issue":"1","key":"52_CR27","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.surg.2013.06.053","volume":"155","author":"CM Thorson","year":"2014","unstructured":"Thorson CM, Van Haren RM, Ryan ML, et al. Pre-existing hypercoagulability in patients undergoing potentially curative cancer resection. Surgery, 2014;155(1):134\u2013144.","journal-title":"Surgery"},{"key":"52_CR28","doi-asserted-by":"publisher","first-page":"9146042","DOI":"10.1155\/2020\/9146042","volume":"2020","author":"T Fang","year":"2020","unstructured":"Fang T, Wang Y, Yin X, et al. Diagnostic Sensitivity of NLR and PLR in Early Diagnosis of Gastric Cancer. J Immunol Res. 2020;2020:9146042.","journal-title":"J Immunol Res."},{"key":"52_CR29","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.939442","volume":"29","author":"X Zhao","year":"2023","unstructured":"Zhao X, Zhou Y, Liu B, et al. Preoperative Neutrophil-Lymphocyte Ratio (NLR)-Binding Fibrinogen-Albumin Ratio (FAR) Is Superior to Platelet-Lymphocyte Ratio (PLR)-Binding Fibrinogen-Albumin Ratio (FAR) and Lymphocyte-Monocyte (LMR)-Binding Fibrinogen-Albumin Ratio (FAR) as Predictors of Survival in Surgical Patients with Colorectal Adenocarcinoma. Med Sci Monit. 2023;29:e939442.","journal-title":"Med Sci Monit."},{"key":"52_CR30","doi-asserted-by":"publisher","first-page":"1450221","DOI":"10.3389\/fneur.2024.1450221","volume":"15","author":"YM Li","year":"2024","unstructured":"Li YM, Xu XH, Ren LN, et al. The diagnostic value of neutrophil to lymphocyte ratio, albumin to fibrinogen ratio, and lymphocyte to monocyte ratio in Parkinson\u2019s disease: a retrospective study. Front Neurol. 2024;15:1450221.","journal-title":"Front Neurol."}],"container-title":["Current Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-025-00052-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11596-025-00052-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-025-00052-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T06:49:14Z","timestamp":1751870954000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11596-025-00052-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,30]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["52"],"URL":"https:\/\/doi.org\/10.1007\/s11596-025-00052-0","relation":{},"ISSN":["2096-5230","2523-899X"],"issn-type":[{"value":"2096-5230","type":"print"},{"value":"2523-899X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,30]]},"assertion":[{"value":"5 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare no conflict of interest regarding the publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Approval for the study protocol was obtained from the Ethics Committee of the First Affiliated Hospital of Harbin Medical University (approval No. 2023 JS49). In terms of the signing of informed consent, since the case data collected in this study were from the previously archived records, we applied for the exemption of the informed consent form in accordance with the ethical requirements of the hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval and Consent to Participate"}},{"value":"This study adhered to the principles outlined in the Declaration of Helsinki and the Ethical Guidelines for Clinical Research.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human Ethics"}},{"value":"This manuscript has not been published elsewhere and has not been submitted to any other journal. All authors have approved the publication of this manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}